Unicycive Announces Acceptance of Four Abstracts for Presentation at the World Congress of Nephrology 2023

January 5, 2023

https://www.globenewswire.com/news-release/2023/01/05/2583527/0/en/Unicycive-Announces-Acceptance-of-Four-Abstracts-for-Presentation-at-the-World-Congress-of-Nephrology-2023.html

LOS ALTOS, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that four abstracts have been accepted for presentation at the upcoming International Society of Nephrology’s World Congress of Nephrology 2023 meeting taking place in Bangkok, Thailand from March 30 – April 2, 2023.

Read more at globenewswire.com

Related news for (UNCY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.